Main menu button

News

Mrkt BUZZ InCoax: Financial targets underpin our growth expectations
26 jun 2024
Mrkt BUZZ InCoax: Financial targets underpin our growth expectations
Equity Research InCoax
Equity Research Nosa Plugs: New orders and distributor agreements
20 jun 2024
Equity Research Nosa Plugs: New orders and distributor agreements
Equity Research Nosa Plugs
Equity research Artificial Solutions: Improved financial strength and proven investor interest
20 jun 2024
Equity research Artificial Solutions: Improved financial strength and proven investor interest
Equity Research Teneo AI
Equity research Svenska Aerogel: New pilot orders and improved finances
20 jun 2024
Equity research Svenska Aerogel: New pilot orders and improved finances
Equity Research Svenska Aerogel
Equity Research Biosergen: Study permission received, BSG005 ready for testing in patients
11 jun 2024
Equity Research Biosergen: Study permission received, BSG005 ready for testing in patients
Equity Research Biosergen
Equity research Enrad: Continued strong order intake bodes well for 2024
10 jun 2024
Equity research Enrad: Continued strong order intake bodes well for 2024
Equity Research Enrad
Equity research, Artificial Solutions: Enabling contact centre excellence through AI
10 jun 2024
Equity research, Artificial Solutions: Enabling contact centre excellence through AI
Equity Research Teneo AI
Equity Research ALM Equity, Q1 2024: 30% NAV discount after price fall
03 jun 2024
Equity Research ALM Equity, Q1 2024: 30% NAV discount after price fall
Equity Research ALM Equity
Equity research Abera Bioscience: Bird flu cases put vaccine companies in the spotlight
31 maj 2024
Equity research Abera Bioscience: Bird flu cases put vaccine companies in the spotlight
Equity Research Abera Bioscience
Equity Research ALM Equity, Q1 2024: Improved gross profit despite lower sales
30 maj 2024
Equity Research ALM Equity, Q1 2024: Improved gross profit despite lower sales
Equity Research ALM Equity
Equity research Abera Bioscience Q1 2024: Increased focus on new projects
23 maj 2024
Equity research Abera Bioscience Q1 2024: Increased focus on new projects
Equity Research Abera Bioscience
Equity research Zinzino, Q1 2024: Solid growth outlook confirmed
23 maj 2024
Equity research Zinzino, Q1 2024: Solid growth outlook confirmed
Equity Research Zinzino
Equity research Zinzino, Q1 2024: Growth and some scalability
22 maj 2024
Equity research Zinzino, Q1 2024: Growth and some scalability
Equity Research Zinzino
Carlsquare weekly market letter: Commodity bull run– when will it affect inflation?
22 maj 2024
Carlsquare weekly market letter: Commodity bull run– when will it affect inflation?
Equity Research Carlsquare
Equity Research GIAB, Q1 2024: Third savings programme to break even
21 maj 2024
Equity Research GIAB, Q1 2024: Third savings programme to break even
Equity Research
Equity Research Ecoclime, Q1 2024: Sales growth possible after weak quarter
20 maj 2024
Equity Research Ecoclime, Q1 2024: Sales growth possible after weak quarter
Equity Research
Equity research Viva Wine Group, Q1 2024: Solid cost control improves longterm outlook
20 maj 2024
Equity research Viva Wine Group, Q1 2024: Solid cost control improves longterm outlook
Equity Research Viva Wine Group
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
17 maj 2024
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
Equity Research Nosa Plugs
Equity Research Ecoclime Q1 2024: A weak quarter but continued growth for Evertherm
16 maj 2024
Equity Research Ecoclime Q1 2024: A weak quarter but continued growth for Evertherm
Equity Research
Equity Research GIAB Q1 2024: Slightly higher sales, but new savings needed
16 maj 2024
Equity Research GIAB Q1 2024: Slightly higher sales, but new savings needed
Equity Research